Physician profile
Jay S Jenoff
NPI 1649323882
$1,310.77
in general payments reported to CMS, 2019-2025
10 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.70 · 2020: $31.77 · 2021: $66.87 · 2022: $139 · 2023: $374 · 2024: $27.38 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978 · Travel and Lodging: $70.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $977.82 |
| Travel and Lodging | $70.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vb Spine LLC | $453.98 | 2025 | Cascadia Interbody System, Monterey Al |
| Spinal Elements, INC. | $297.96 | 2023 | |
| Baxter Healthcare | $231.61 | 2021-2025 | Floseal, Seprafilm |
| Zimmer Biomet Holdings, INC. | $152.27 | 2020-2022 | |
| Aroa Biosurgery Incorporated | $49.12 | 2023 | |
| Smith+Nephew, INC. | $28.20 | 2025 | Oasis, Collagenase Santyl, Versajet |
| Stryker Corporation | $27.38 | 2024 | Everest Spinal System |
| Kerecis Limited | $26.80 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Avita Medical Americas, LLC | $24.70 | 2019 | |
| Z-Medica, LLC | $18.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Jenoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.